SAUDI ARABIA – King Faisal Specialist Hospital and Research Centre (KFSH&RC) has entered into a strategic collaboration agreement with Jameel Clinic, the epicenter of artificial intelligence (AI) in healthcare at the Massachusetts Institute of Technology (MIT).
Jameel Clinic was co-founded by MIT and Community Jameel, an organisation of the Jameel family, owners of the Abdul Latif Jameel business.
Abdul Latif Jameel is a family-owned diversified business founded in Saudi Arabia in 1945 by the late Sheikh Abdul Latif Jameel (1909–1993).
Through the new agreement, KFSH&RC and the MIT Jameel Clinic will work closely on clinical artificial intelligence (AI) research projects as well as speed up the development of advanced AI tools.
King Faisal Specialist Hospital and Research Centre and the MIT Jameel Clinic have formed a strategic partnership covering three key areas to drive forward the field of clinical AI.
These 3 focus areas include developing new AI Tools, broad testing for equitable health outcomes, and refining AI tool development.
The joint statement said: “This collaboration holds immense importance for both organizations as they strive to enhance patient care, improve clinical outcomes, and reduce healthcare costs through the development and implementation of advanced AI tools.”
The strategic agreement will combine KFSH&RC’s integrated educational and research setting with MIT Jameel Clinic’s expertise in the field of artificial intelligence and health sciences to accelerate the adoption of Applied Artificial Intelligence (AI) in healthcare.
Through their joint efforts, KFSH&RC and MIT Jameel Clinic aim to usher in a new era of healthcare, marked by improved patient outcomes, increased efficiency, and enhanced accessibility to high-quality care.
The agreement aligns with KFSH&RC’s mission to serve society with the highest level of healthcare and the best patient experience in an integrated education and research setting.
Commenting on this partnership, Dr. Osama Alswailem, Chief Information Officer at KFSH&RC, said: “Together, we aspire to pioneer cutting-edge solutions that effectively address healthcare needs, leading the way towards transformative advancements.”
KFSH&RC and MIT Jameel Clinic will combine their unique strengths and expertise to develop safe and effective procedures for deploying AI tools in specific clinical contexts.
As part of the new agreement, KFSH&RC and MIT Jameel Clinic will ensure that AI tools are seamlessly integrated into diverse healthcare settings, along with the optimization of these AI tools in clinical utility.
The partnership will also include the broad testing of AI tools in diverse patient populations, with a focus on ensuring equitable health outcomes for all individuals
To this end, KFSH&RC and MIT Jameel Clinic will be testing AI tools across a wide range of demographics and clinical facilities to support the attainment of equitable healthcare outcomes.
King Faisal Specialist Hospital and Research Centre and MIT Jameel Clinic have also pledged to continuously refine the development of AI tools.
Through iterative feedback and evaluation, the partnership will optimize the clinical utility of these AI tools, as well as, ensure their effectiveness, safety, and ability to deliver the highest quality of patient care.
On her part, Fotini Christia, Ford International Professor of the Social Sciences at MIT & Director of the Sociotechnical Systems Research Center, stated: “The integration of AI technology has the power to enhance the quality, efficiency, and accessibility of healthcare, and ultimately transforming the healthcare landscape for all.”
Fotini Christia emphasized the potential impact of clinical AI on revolutionizing the healthcare industry, noting that the integration of AI technology has the power to make real differences in the lives of patients worldwide.